177 related articles for article (PubMed ID: 23055525)
21. Quantity of partial agonist activity for antiglucocorticoids complexed with mutant glucocorticoid receptors is constant in two different transactivation assays but not predictable from steroid structure.
Sarlis NJ; Bayly SF; Szapary D; Simons SS
J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):89-102. PubMed ID: 10369406
[TBL] [Abstract][Full Text] [Related]
22. Kinetically-defined component actions in gene repression.
Chow CC; Finn KK; Storchan GB; Lu X; Sheng X; Simons SS
PLoS Comput Biol; 2015 Mar; 11(3):e1004122. PubMed ID: 25816223
[TBL] [Abstract][Full Text] [Related]
23. Interaction of silencing mediator for retinoid and thyroid receptors with steroid and xenobiotic receptor on multidrug resistance 1 promoter.
Hirooka-Masui K; Lesmana R; Iwasaki T; Xu M; Hayasaka K; Haraguchi M; Takeshita A; Shimokawa N; Yamamoto K; Koibuchi N
Life Sci; 2013 May; 92(17-19):911-5. PubMed ID: 23562850
[TBL] [Abstract][Full Text] [Related]
24. Steroid-nucleoside interactions with receptors.
Zava DT; McGuire WL; van Lier JE
J Steroid Biochem; 1978 Dec; 9(12):1155-8. PubMed ID: 745411
[No Abstract] [Full Text] [Related]
25. Vanadate increases glucocorticoid receptor-mediated gene expression: a novel mechanism for potentiation of a steroid receptor.
Li Calzi S; Periyasamy S; Li DP; Sánchez ER
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):35-47. PubMed ID: 11867262
[TBL] [Abstract][Full Text] [Related]
26. Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) regulates glucocorticoid action in adipocytes.
Emont MP; Mantis S; Kahn JH; Landeche M; Han X; Sargis RM; Cohen RN
Mol Cell Endocrinol; 2015 May; 407():52-6. PubMed ID: 25766503
[TBL] [Abstract][Full Text] [Related]
27. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
Stevens A; Garside H; Berry A; Waters C; White A; Ray D
Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
Ki SH; Cho IJ; Choi DW; Kim SG
Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
[TBL] [Abstract][Full Text] [Related]
29. Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression.
Tao YG; Xu Y; Xu HE; Simons SS
Biochemistry; 2008 Jul; 47(29):7648-62. PubMed ID: 18578507
[TBL] [Abstract][Full Text] [Related]
30. Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.
Ojasoo T; Doré JC; Gilbert J; Raynaud JP
J Med Chem; 1988 Jun; 31(6):1160-9. PubMed ID: 2897467
[TBL] [Abstract][Full Text] [Related]
31. Bag-1M inhibits the transactivation of the glucocorticoid receptor via recruitment of corepressors.
Hong W; Baniahmad A; Li J; Chang C; Gao W; Liu Y
FEBS Lett; 2009 Aug; 583(15):2451-6. PubMed ID: 19595997
[TBL] [Abstract][Full Text] [Related]
32. Selective enhancement of gene transfer by steroid-mediated gene delivery.
Rebuffat A; Bernasconi A; Ceppi M; Wehrli H; Verca SB; Ibrahim M; Frey BM; Frey FJ; Rusconi S
Nat Biotechnol; 2001 Dec; 19(12):1155-61. PubMed ID: 11731785
[TBL] [Abstract][Full Text] [Related]
33. STAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid receptor-mediated induction and repression.
He Y; Simons SS
Mol Cell Biol; 2007 Feb; 27(4):1467-85. PubMed ID: 17116691
[TBL] [Abstract][Full Text] [Related]
34. Differential modulation of glucocorticoid and progesterone receptor transactivation.
Szapary D; Song LN; He Y; Simons SS
Mol Cell Endocrinol; 2008 Feb; 283(1-2):114-26. PubMed ID: 18215457
[TBL] [Abstract][Full Text] [Related]
35. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
36. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
37. Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line.
Waters CE; Stevens A; White A; Ray DW
J Endocrinol; 2004 Nov; 183(2):375-83. PubMed ID: 15531725
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays.
Fuhrmann U; Slater EP; Fritzemeier KH
Contraception; 1995 Jan; 51(1):45-52. PubMed ID: 7750284
[TBL] [Abstract][Full Text] [Related]
39. Steroid hormone receptors in normal human lymphocytes. Induction of glucocorticoid receptor activity by phytohemagglutinin stimulation.
Neifeld JP; Lippman ME; Tormey DC
J Biol Chem; 1977 May; 252(9):2972-7. PubMed ID: 856808
[TBL] [Abstract][Full Text] [Related]
40. GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression.
Hua G; Paulen L; Chambon P
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E626-34. PubMed ID: 26712002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
